We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Updated: 2/23/2016
A Trial Comparing Efficacy and Safety of NN1250 and Insulin Glargine in Subjects With Type 2 Diabetes (BEGIN™: LOW VOLUME)
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
The Health Outcomes Management and Evaluation (HOME) Study
Updated: 2/25/2016
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated: 2/25/2016
The Health Outcomes Management and Evaluation (HOME) Study
Updated: 2/25/2016
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
Updated: 2/26/2016
The Effect of the Beta 2 Agonist, Formoterol, on Recovery From Hypoglycemia
Status: Enrolling
Updated: 2/26/2016
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
Updated: 2/26/2016
The Effect of the Beta 2 Agonist, Formoterol, on Recovery From Hypoglycemia
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
Updated: 2/29/2016
A Double-Blind, Randomized, Placebo Controlled Intervention Study to Assess the Impact of Sitagliptin 100 mg/Day for 1 Year on Insulin Independence Following Pancreatectomy and Autoislet Transplantation
Status: Enrolling
Updated: 2/29/2016
Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
Updated: 2/29/2016
A Double-Blind, Randomized, Placebo Controlled Intervention Study to Assess the Impact of Sitagliptin 100 mg/Day for 1 Year on Insulin Independence Following Pancreatectomy and Autoislet Transplantation
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Updated: 2/29/2016
Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials